Synthesis of 1,3-Disubstituted N-Amino-1,2,3,4-tetrahydroisoquinolines

Li Zhang; Xiu-Fang Zheng; Gregory Linn; Kang Zhao

doi:10.1055/s-2007-967948

LETTER

Synthesis of 1,3-Disubstituted N-Amino-1,2,3,4-tetrahydroisoquinolines

Li Zhang, Xiu-Fang Zheng, Gregory Linn, Kang Zhao*
School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, P. R. of China
Fax: +86(22)27890968; e-Mail: kangzhao@tju.edu.cn;

Abstract

Alle Artikel dieser Rubrik

Abstract

The synthesis of 1,3-disubstituted N-amino-1,2,3,4-tetrahydroisoquinolines from the corresponding hydrazide intermediate via Pictet-Spengler reaction is described and the effect of the aldehyde on the stereoconfiguration of the products is discussed.

Key words

quinolines - aldehydes - heterocycles - reduction - ring closure

Volltext

Referenzen

References and Notes

1 Dong H. Sheng JZ. Wong TM. Br. J. Pharmacol. 1993, 109: 109

2 Dong H. Lee CM. Huang WL. Peng SX. Br. J. Pharmacol. 1992, 107: 262

3 Chandrasekhar S. Mohanty PK. Harikishan K. Sasmal PK. Org. Lett. 1999, 1: 877 ; and references cited therein

4 Scott JD. Williams RM. Chem. Rev. 2002, 102: 1669

5 Vecchietti V. Clarke GD. Colle R. Giardina G. Petrone G. Sbacchi M. J. Med. Chem. 1991, 34: 2624

6a Gremmen C. Wanner MJ. Koomen G.-J. Tetrahedron Lett. 2001, 42: 8885

6b Kotake Y. Tasaki Y. Makino Y. Ohta S. Hirobe M. J. Neurochem. 1995, 65: 2633

6c Grunewald GL. Sall DJ. Monn JA. J. Med. Chem. 1998, 31: 824

7a Gitto R. Barreca ML. De Luca L. De Sarro G. Ferreri G. Quartarone S. Russo E. Constanti A. Chimirri A. J. Med. Chem. 2003, 46: 197

7b Ferreri G. Chimirri A. Russo E. Gitto R. Gareri P. De Sarro A. De Sarro G. Pharmacol. Biochem. Behav. 2004, 77: 85

8a Gray NM. Cheng BK. Mick SJ. Lair CM. Contrera PC. J. Med. Chem. 1989, 32: 1242

8b Horiguchi Y. Kodama H. Nakamura M. Yoshimura T. Hanezi K. Hamada H. Saitoh T. Sano T. Chem. Pharm. Bull. 2002, 50: 253

9a Zalán Z. Martinek TA. Lázár L. . Fülöp F. Tetrahedron 2006, 62: 2883

9b Biel JH. inventors; US Patent, 3037984. ; Chem. Abstr. 1962, 57, 15082a

9c Biel JH. inventors; US Patent, 2932646. ; Chem. Abstr. 1960, 54, 17435h

10 Dutta AS. Morley JS. J. Chem. Soc., Perkin Trans. 1 1975, 1712

11

All melting points were determined on a Kofler hot-plate microscope apparatus and are uncorrected. Mass spectra ESI were recorded on Q-TOF Micromass spectrometer. ¹H NMR and ¹³C NMR spectra were recorded on a Varian Inova 500 MHz instrument.
Selected data of compounds 5:
5a: mp 109-110 °C. ¹H NMR (CDCl₃): δ = 7.76 (br s, 1 H, anti), 7.85 (br s, 1 H, syn), 6.79-6.83 (m, 2 H, 2 isomers), 6.75-6.77 (m, 2 H, anti), 6.66-6.68 (m, 2 H, syn), 6.74 (s, 1 H, anti), 6.62 (br s, 1 H, syn), 3.85-3.87 (m, 9 H, 2 isomers), 3.57 (d, J = 4.0 Hz, 2 H, anti), 3.52 (br s, 2 H, syn), 1.71 (d, J = 1.0 Hz, 3 H, anti), 2.06 (d, J = 6.5 Hz, 3 H, syn). MS (ESI): m/z = 267.0 [M + H]⁺. 5b: mp 144-146 °C. ¹H NMR (CDCl₃): δ = 8.75 (br s, 1 H, anti), 8.99 (br s, 1 H, syn), 7.83 (br s, 2 H, anti), 7.60 (d, J = 16.0 Hz, 2 H, syn), 7.52-7.54 (m, 1 H, anti), 7.49-7.52 (m, 2 H + 1 H′), 7.36 (t, J = 7.5 Hz, 2 H, syn), 6.81 (s, 3 H, anti), 6.71 (s, 3 H, syn), 3.86 (s, 3 H, anti), 3.88 (s, 3 H, syn), 3.85-3.86 (m, 3 H, 2 isomers), 3.63-3.69 (m, 2 H, 2 isomers), 1.86 (s, 3 H, anti), 2.15 (s, 3 H, syn). MS (ESI): m/z = 313.0 [M + H]⁺.

12

Selected data of compounds 6:
6a: mp 114-116 °C. ¹H NMR (CDCl₃): δ = 7.60 (d, J = 7.0 Hz, 2 H), 7.49 (t, J = 2.0 Hz, 1 H), 7.40 (t, J = 2.5 Hz, 2 H), 7.30-7.32 (m, 2 H), 7.20-7.26 (m, 3 H), 4.49 (br s, 1 H), 3.40 (sext, J = 6.5 Hz, 1 H), 2.83 (q, J = 6.5 Hz, 1 H), 2.67 (q, J = 7.0 Hz, 1 H), 1.13 (d, J = 6.0 Hz, 3 H). MS (ESI): m/z = 255.2 [M + H]⁺. 6b: ¹H NMR (CDCl₃): δ = 7.16 (td, J = 8.0, 9.5 Hz, 1 H), 7.16 (dd, J = 1.5, 7.5 Hz, 1 H), 6.86 (td, J = 7.5, 8.5 Hz, 1 H), 6.80 (d, J = 8.5 Hz, 1 H), 4.01 (sext, J = 6.0 Hz, 1 H), 3.73 (s, 3 H), 2.71-2.76 (m, 2 H), 1.16 (s, 3 H). MS (ESI): m/z = 181.4 [M + H]⁺. 6f: mp 82-84 °C. ¹H NMR (CDCl₃): δ = 7.61-7.63 (m, 2 H), 7.48-7.52 (m, 1 H), 7.39-7.42 (m, 2 H), 7.68-7.87 (m, 2 H), 7.14-7.17 (m, 2 H), 3.79 (s, 3 H), 3.37 (sext, J = 6.5 Hz, 1 H), 2.78 (q, J = 7.0 Hz, 1 H), 2.64 (q, J = 6.5 Hz, 1 H), 1.14 (d, J = 6.5 Hz, 3 H). MS (ESI): m/z = 285.4 [M + H]⁺.

13a Bates HA. J. Org. Chem. 1983, 48: 1932

13b Cox ED. Cook JM. Chem. Rev. 1995, 95: 1797

13c Nakamura S. Tanaka M. Taniguchi T. Uchiyama M. Ohwada T. Org. Lett. 2003, 5: 2087

13d Magnus P. Matthews KS. Lynch V. Org. Lett. 2003, 5: 2181

13e Munchhof MJ. Meyers AI. J. Org. Chem. 1996, 61: 4607

14

Compound 7a: ¹H NMR (300 MHz, DMSO-d ₆): δ = 11.21 (br s, 1 H), 7.99 (s, 1 H), 7.57-7.63 (m, 4 H) 3.69 (s, 3 H). 7b: ¹H NMR (300 MHz, DMSO-d ₆): δ = 11.87 (br s, 1 H), 8.47 (s, 1 H), 7.92 (d, J = 7.5 Hz, 2 H), 7.74 (d, J = 5.4 Hz, 2 H), 7.46-7.61 (m, 6 H).

15

3b: Crystallized in triclinic, space group P-1 with cell parameters: a = 5.2532(11) Å, b = 10.676(2) Å, c = 20.717(4) Å, α = 101.19°, β = 93.87°, γ = 102.61°, V = 1104.9(4) Å³, D _c = 1.447 g/cm³, Z = 2.

16

Synthesis of compound 3: To the mixture of compound 6a (200 mg, 0.64 mmol) and 4-bromobenzaldehyde (118 mg, 0.64 mmol) in MeCN (8 mL), anhyd NaI (334 mg, 2.23 mmol) was added under stirring at r.t., followed by TMSCl (0.28 mL, 2.23 mmol). After 40 min, the reaction was concentrated and the products were purified by column chromatography (10-30% EtOAc-PE). Unless otherwise indicated, each product was separated as an enantiomeric mixture and characterized by NMR spectroscopy.
Selected data of compounds 3:
3a: mp 227-229 °C. ¹H NMR (CDCl₃): δ = 7.43-7.47 (m, 1 H), 7.39-7.42 (m, 4 H), 7.34 (t, J = 7.5 Hz, 2 H), 7.22 (d, J = 8.0 Hz, 2 H), 6.96 (br s, 1 H), 6.63 (d, J = 2.5 Hz, 1 H), 6.59 (dd, J = 2.5, 8.5 Hz, 1 H), 6.49 (d, J = 8.5 Hz, 1 H), 5.81 (br s, 1 H), 4.12 (br s, 1 H), 3.76 (s, 3 H), 3.00 (br s, 1 H), 2.88 (dd, J = 3.5, 16.0 Hz, 1 H), 1.29 (d, J = 6.5 Hz, 3 H). ¹³C NMR (CDCl₃): δ = 167.65, 158.03, 142.74, 135.33, 133.78, 131.56, 131.51, 131.19, 129.34, 128.65, 126.64, 121.45, 112.37, 112.25, 66.56, 55.19, 54.11, 39.01, 19.70. MS (ESI): m/z = 451.2, 453.2 [M + H]⁺. 3b: mp 216-217 °C. ¹H NMR (CDCl₃): δ = 7.41-7.47 (m, 5 H), 7.35 (t, J = 7.5 Hz, 2 H), 7.23 (d, J = 7.5 Hz, 2 H), 6.99 (br s, 1 H), 6.59 (s, 1 H), 6.04 (s, 1 H), 5.83 (br s, 1 H), 4.14 (br s, 1 H), 3.85 (s, 3 H), 3.59 (s, 3 H), 2.96 (br s, 1 H), 2.82 (dd, J = 2.5, 15.5 Hz, 1 H), 1.28 (d, J = 6.0 Hz, 3 H). ¹³C NMR (CDCl₃): δ = 167.65, 147.78, 147.26, 142.61, 133.75, 131.56, 131.50, 131.21, 129.39, 128.65, 126.65, 126.41, 121.50, 111.08, 110.45, 66.38, 55.90, 55.84, 53.84, 38.38, 19.67. MS (ESI): m/z = 481.0, 483.0 [M + H]⁺. 3c: mp 171-172 °C. ¹H NMR (CDCl₃): δ = 7.40-7.56 (m, 5 H, 2 isomers), 7.15-7.18 (trans), 7.03-7.05 (m, 4 H, cis), 6.70 (br s, 1 H, 2 isomers), 6.43 (s, 1 H, trans), 6.49 (s, 1 H, cis), 5.69 (br s, 1 H, trans), 5.37 (s, 1 H, cis), 4.00 (br s, 1 H, trans), 3.24-3.26 (m, 1 H, cis), 3.86 (s, 3 H, trans), 3.87 (s, 3 H, cis), 3.73 (s, 3 H, trans), 3.79 (s, 3 H, cis), 3.14 (s, 3 H, trans), 3.46 (s, 3 H, cis), 2.95 (br s, 1 H, 2 isomers), 2.74-2.83 (m, 1 H, 2 isomers), 1.23 (d, J = 6.0 Hz, 3 H, trans), 1.17 (d, J = 6.0 Hz, 3 H, cis). ¹³C NMR (CDCl₃): δ (trans/cis) = 166.35/167.48, 152.56/153.22, 150.70/151.06, 140.57/144.76, 140.46/139.35, 133.75/134.04, 131.61/131.45, 131.17/130.87, 130.81/130.77, 128.67/129.32, 126.76/127.04, 121.61/123.79, 120.43/119.81, 106.14/106.56, 64.05/60.71, 60.50/60.38, 59.12/60.16, 55.87/55.93, 48.52/53.08, 39.53/32.95, 19.63/18.86. MS (ESI): m/z = 511.1, 513.1 [M + H]⁺. 3d: mp 215-218 °C. ¹H NMR (CDCl₃): δ = 7.42 (t, J = 7.5 Hz, 1 H), 7.34-7.36 (m, 4 H), 7.27-7.33 (m, 5 H), 6.95 (br s, 1 H), 6.59 (s, 1 H), 6.09 (s, 1 H), 5.79 (br s, 1 H), 4.13 (br s, 1 H), 3.85 (s, 3 H), 3.56 (s, 3 H), 2.97 (br s, 1 H), 2.83 (dd, J = 3.5, 15.5 Hz, 1 H), 1.30 (d, J = 6.0 Hz, 3 H). ¹³C NMR (CDCl₃): δ = 167.75, 147.63, 147.14, 143.33, 134.07, 131.36, 130.08, 129.52, 128.53, 128.38, 127.65, 126.68, 126.38, 113.31, 110.38, 68.07, 55.83, 54.06, 38.46, 19.73. MS (ESI): m/z = 403.3 [M + H]⁺. 3e (trans): mp 210-211 °C. ¹H NMR (CDCl₃): δ = 7.42-7.45 (m, 3 H), 7.33 (t, J = 7.5 Hz, 2 H), 7.25 (d, J = 8.5 Hz, 2 H), 6.91 (br s, 1 H), 6.82 (d, J = 8.5 Hz, 2 H), 6.58 (s, 1 H), 6.10 (s, 1 H), 5.73 (br s, 1 H), 4.10 (br s, 1 H), 3.85 (s, 3 H), 3.78 (s, 3 H), 3.58 (s, 3 H), 2.96 (br s, 1 H), 2.82 (dd, J = 3.5, 15.5 Hz, 1 H), 1.29 (d, J = 6.0 Hz, 3 H). ¹³C NMR (CDCl₃): δ = 167.79, 158.98, 147.60, 147.12, 135.37, 134.12, 131.36, 130.59, 130.29, 128.55, 126.70, 126.37, 113.69, 111.34, 110.33, 55.86, 55.21, 38.39, 19.78. MS (ESI): 433.1 [M + H]⁺. 3e (cis): mp 210-211 °C. ¹H NMR (CDCl₃): δ = 7.66 (d, J = 7.5 Hz, 2 H), 7.48 (t, J = 7.5 Hz, 1 H), 7.40 (t, J = 7.5 Hz, 2 H), 7.19 (d, J = 8.5 Hz, 2 H), 6.85 (d, J = 9.0 Hz, 2 H), 6.75 (s, 1 H), 6.66 (s, 1 H), 6.39 (s, 1 H), 5.18 (s, 1 H), 3.90 (s, 3 H), 3.79 (s, 3 H), 3.72 (s, 3 H), 3.36 (sept, J = 6.0 Hz, 1 H), 2.90 (dd, J = 5.0, 17.0 Hz, 1 H), 2.82 (dd, J = 10.0, 17.0 Hz, 1 H), 1.17 (d, J = 6.5 Hz, 3 H). ¹³C NMR (CDCl₃): δ = 166.18, 159.10, 148.23, 147.70, 134.18, 132.46, 131.50, 131.21, 128.60, 127.02, 126.20, 125.72, 113.54, 111.46, 110.84, 67.83, 55.87, 55.27, 49.04, 33.05, 18.26. MS (ESI): m/z = 433.1 [M + H]⁺. 3f (p, cis): mp 202-204 °C. MS (ESI): m/z = 437.1, 439.1 [M + H]⁺. 3f (m, trans): mp 182-183 °C. MS (ESI): m/z = 437.1, 439.1 [M + H]⁺. 3f (o): mp 99-101 °C. MS (ESI): m/z = 437.1, 439.1 [M + H]⁺. 3g: mp 203-206 °C. ¹H NMR (DMSO-d ₆): δ = 9.43 (br s, 1 H), 8.12 (d, J = 8.5 Hz, 2 H), 7.63 (br s, 2 H) 7.49 (d, J = 7.5 Hz, 2 H) 7.45 (t, J = 7.5 Hz, 1 H), 7.36 (t, J = 7.5 Hz, 2 H), 6.74 (s, 1 H), 6.02 (s, 1 H), 5.24 (br s, 1 H), 3.71 (s, 3 H), 3.42 (s, 3 H), 3.23 (br s, 1 H), 2.91 (br s, 1 H), 2.83 (dd, J = 3.0, 16.0 Hz, 1 H), 1.17 (d, J = 6.0 Hz, 3 H). ¹³C NMR (125 Hz, CDCl₃): δ = 167.40, 151.23, 148.08, 147.46, 147.41, 133.33, 131.70, 130.25, 128.63, 126.56, 126.49, 123.53, 110.83, 110.73, 67.78, 55.88, 55.83, 54.47, 38.29, 19.48. MS (ESI): m/z = 448.2 [M + H]⁺. 3h: mp 158-160 °C. ¹H NMR (CDCl₃): δ = 7.72 (d, J = 7.0 Hz, 2 H), 7.50 (t, J = 7.5 Hz, 1 H), 7.42 (t, J = 7.5 Hz, 2 H), 7.08 (br s, 1 H), 6.60 (s, 1 H), 6.52 (s, 1 H), 4.36 (d, J = 10.0 Hz, 1 H), 4.12 (d, J = 15.0 Hz, 1 H), 3.86 (s, 3 H), 3.84 (s, 3 H), 3.45 (br s, 1 H), 2.73-2.84 (m, 2 H), 1.30 (d, J = 6.5 Hz, 3 H). ¹³C NMR (CDCl₃): δ = 166.65, 147.85, 147.63, 133.81, 131.49, 128.49, 126.97, 125.04, 123.97, 111.13, 109.32, 56.94, 55.80, 55.45, 33.13, 18.69. MS (ESI): m/z = 327.1 [M + H]⁺. 3i (trans): mp 184-186 °C. ¹H NMR (CDCl₃): δ = 7.71 (d, J = 7.5 Hz, 2 H), 7.51 (t, J = 7.5 Hz, 1 H), 7.43 (t, J = 7.5 Hz, 2 H), 6.82 (br s, 1 H), 6.68 (s, 1 H), 6.57 (s, 1 H), 4.31 (br s, 1 H), 3.87 (s, 3 H), 3.86 (s, 3 H), 3.46 (br s, 1 H), 2.77-2.82 (m, 1 H), 2.67 (dd, J = 3.5, 16.5 Hz, 1 H), 1.93-2.00 (m, 1 H), 1.73-1.80 (m, 1 H), 1.56-1.63 (m, 1 H), 1.40 (m, 1 H), 1.27 (d, J = 6.5 Hz, 3 H), 0.90 (t, J = 6.0 Hz, 3 H). ¹³C NMR (CDCl₃): δ = 167.18, 147.67, 147.60, 134.21, 131.53, 128.68, 128.43, 126.92, 110.92, 109.34, 64.22, 56.06, 55.85, 35.84, 35.19, 19.82, 18.31, 14.57. MS (ESI): m/z = 369.3 [M + H]⁺. 3i (cis): mp 183-184 °C. MS (ESI): m/z = 369.3 [M + H]⁺. 3k (trans): mp 170-172 °C. ¹H NMR (CDCl₃): δ = 7.59 (d, J = 7.0 Hz, 2 H), 7.48-7.51 (m, 1 H), 7.39-7.42 (m, 2 H), 7.23-7.26 (m, 4 H), 7.14-7.17 (m, 1 H), 7.01 (br s, 1 H), 6.53 (s, 1 H), 6.46 (s, 1 H), 4.73 (br s, 1 H, H_a), 3.84 (s, 3 H), 3.63 (s, 3 H), 3.54-3.56 (m, 1 H, H_e), 3.28 (dd, J _ee = 5.0 Hz, J _ea = 14.0 Hz, 1 H, H_e), 3.09 (dd, J _aa = 6.5 Hz, J _ae = 14.0 Hz, 1 H, H_a), 2.65 (dd, J _aa = 11.0 Hz, J _ae = 16.0 Hz, 1 H, H_a), 2.59 (dd, J _ea = 3.5 Hz, J _ea = 16.0 Hz, 1 H, H_e), 1.23 (d, J = 6.0 Hz, 3 H).
¹³C NMR (CDCl₃): δ = 167.14, 147.41, 147.20, 139.87, 133.79, 131.61, 129.61, 129.03, 128.59, 128.30, 126.87, 126.81, 126.04, 110.63, 109.99, 66.23, 55.82, 55.69, 55.06, 43.72, 36.26, 20.04. MS (ESI): m/z = 417.3 [M + H]⁺. 3m: mp 195-196 °C. ¹H NMR (CDCl₃): δ = 7.44-7.51 (m,
3 H + 1 H′), 7.71 (d, J = 7.5 Hz, 2 H, cis), 7.34-7.37 (m, 2 H, trans), 7.41 (t, J = 7.5 Hz, 2 H, cis), 7.26 (d, J = 4.0 Hz, 1 H, trans), 7.31 (d, J = 4.0 Hz, 1 H, cis), 7.19 (br s, 1 H, 2 isomers), 7.11 (d, J = 3.0 Hz, 1 H, trans), 6.84 (d, J = 3.0 Hz, 1 H, cis), 6.91 (dd, J = 3.5, 5.5 Hz, 1 H, trans), 6.98 (dd, J = 3.5, 5.5 Hz, 1 H, cis), 6.58 (s, 1 H, trans), 6.63 (s, 1 H, cis), 6.32 (s, 1 H, trans), 6.48 (s, 1 H, cis), 6.17 (br s, 1 H, trans), 5.50 (s, 1 H, cis), 4.11 (br s, 1 H, trans), 3.42-3.49 (m, 1 H, cis), 3.86 (s, 1 H, trans), 3.88 (s, 1 H, cis), 3.64 (s, 1 H, trans), 3.75 (s, 1 H, cis), 2.84-2.96 (m, 1 H, 2 isomers), 2.80 (dd, J = 3.5, 15.5 Hz, 1 H, 2 isomers), 1.30 (d, J = 6.5 Hz, 3 H, trans), 1.24 (d, J = 6.5 Hz, 3 H, cis). ¹³C NMR (CDCl₃): δ (trans/cis)= 167.85/166.05, 147.87/148.48, 147.24/147.60, 133.88/133.92, 131.49/131.58, 128.58/128.61, 127.47/127.00, 126.75/126.55, 125.96/125.92, 125.85/125.36, 110.96/111.11, 110.37/110.58, 63.68/62.86, 55.80/55.85, 49.77/54.66, 38.11/34.52, 19.74/18.78. MS (ESI): m/z = 409.4 [M + H]⁺. 3n (trans): mp 192-194 °C. ¹H NMR (CDCl₃): δ = 8.44 (d, J = 5.5 Hz, 2 H), 7.61 (br s, 1 H), 7.43-7.55 (m, 3 H), 7.30-7.34 (m, 2 H), 7.27-7.28 (m, 2 H), 6.61 (s, 1 H), 6.02 (s, 1 H), 5.86 (br s, 1 H), 4.00 (br s, 1 H), 3.85 (s, 3 H), 3.58 (s, 3 H), 2.95 (br s, 1 H), 2.82 (dd, J = 3.5, 15.5 Hz, 1 H), 1.27 (d, J = 6.0 Hz, 3 H). MS (ESI): m/z = 404.4 [M + H]⁺.

17 Davis FA. Mohanty PK. Burns DM. Andemichael YW. Org. Lett. 2000, 2: 3901

18a Rezessy B. Sólyom S. Lett. Drug Des. Discov. 2004, 1: 217

18b Barreca ML. Gitto R. Quartarone S. De Luca L. De Sarro G. Chimirri A. J. Chem. Inf. Comput. Sci. 2003, 43: 651